These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35343622)

  • 1. Geometric approaches to assessing the numerical feasibility for conducting matching-adjusted indirect comparisons.
    Glimm E; Yau L
    Pharm Stat; 2022 Sep; 21(5):974-987. PubMed ID: 35343622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-stage matching-adjusted indirect comparison.
    Remiro-Azócar A
    BMC Med Res Methodol; 2022 Aug; 22(1):217. PubMed ID: 35941551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: applying matching-adjusted indirect comparison methodology.
    Sikirica V; Findling RL; Signorovitch J; Erder MH; Dammerman R; Hodgkins P; Lu M; Xie J; Wu EQ
    CNS Drugs; 2013 Nov; 27(11):943-53. PubMed ID: 23975660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the double-robustness and semiparametric efficiency of matching-adjusted indirect comparisons.
    Cheng D; Tchetgen ET; Signorovitch J
    Res Synth Methods; 2023 May; 14(3):438-442. PubMed ID: 36537355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison.
    Cohan S; Kumar J; Arndorfer S; Zhu X; Zivkovic M; Tencer T
    CNS Drugs; 2021 Jul; 35(7):795-804. PubMed ID: 33847901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of unanchored matching-adjusted indirect comparison (MAIC) for the evidence synthesis of single-arm trials with time-to-event outcomes.
    Jiang Y; Ni W
    BMC Med Res Methodol; 2020 Sep; 20(1):241. PubMed ID: 32993519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equivalence of entropy balancing and the method of moments for matching-adjusted indirect comparison.
    Phillippo DM; Dias S; Ades AE; Welton NJ
    Res Synth Methods; 2020 Jul; 11(4):568-572. PubMed ID: 32395870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the impact of a matching-adjusted indirect comparison in a Bayesian network meta-analysis.
    Leahy J; Walsh C
    Res Synth Methods; 2019 Dec; 10(4):546-568. PubMed ID: 31368653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Adjusted and Unadjusted Indirect Comparison Methods in Benefit Assessment. A Simulation Study for Time-to-event Endpoints.
    Kühnast S; Schiffner-Rohe J; Rahnenführer J; Leverkus F
    Methods Inf Med; 2017 May; 56(3):261-267. PubMed ID: 28361159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative weighting schemes when performing matching-adjusted indirect comparisons.
    Jackson D; Rhodes K; Ouwens M
    Res Synth Methods; 2021 May; 12(3):333-346. PubMed ID: 33131206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect comparison of the antiviral efficacy of peginterferon alpha 2a plus ribavirin used with or without simeprevir in genotype 4 hepatitis C virus infection, where common comparator study arms are lacking: a special application of the matching adjusted indirect comparison methodology.
    Van Sanden S; Pisini M; Duchesne I; Mehnert A; Belsey J
    Curr Med Res Opin; 2016; 32(1):147-54. PubMed ID: 26455472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research.
    Signorovitch JE; Sikirica V; Erder MH; Xie J; Lu M; Hodgkins PS; Betts KA; Wu EQ
    Value Health; 2012; 15(6):940-7. PubMed ID: 22999145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments.
    Kapetanakis V; Prawitz T; Schlichting M; Ishak KJ; Phatak H; Yu T; Bharmal M
    Value Health; 2021 Aug; 24(8):1137-1144. PubMed ID: 34372979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Matching-Adjusted Indirect Comparisons in Practice: A Case Study of Patients with Attention-Deficit/Hyperactivity Disorder.
    Shafrin J; Shrestha A; Chandra A; Erder MH; Sikirica V
    Health Econ; 2017 Nov; 26(11):1459-1466. PubMed ID: 27620206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive review and shiny application on the matching-adjusted indirect comparison.
    Jiang Z; Cappelleri JC; Gamalo M; Chen Y; Thomas N; Chu H
    Res Synth Methods; 2024 Jul; 15(4):671-686. PubMed ID: 38380799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2- advanced breast cancer.
    Tremblay G; Chandiwana D; Dolph M; Hearnden J; Forsythe A; Monaco M
    Cancer Manag Res; 2018; 10():1319-1327. PubMed ID: 29861642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of several matching adjusted indirect comparisons (MAICs) with an application in psoriasis.
    Saure D; Schacht A; Kadziola Z; Brnabic AJM
    Pharm Stat; 2020 Sep; 19(5):532-540. PubMed ID: 32115845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel.
    Cartron G; Fox CP; Liu FF; Kostic A; Hasskarl J; Li D; Bonner A; Zhang Y; Maloney DG; Kuruvilla J
    Exp Hematol Oncol; 2022 Mar; 11(1):17. PubMed ID: 35337365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Model Misspecification in Unanchored Matching-Adjusted Indirect Comparison: Results of a Simulation Study.
    Hatswell AJ; Freemantle N; Baio G
    Value Health; 2020 Jun; 23(6):751-759. PubMed ID: 32540233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the comparative efficacy of cladribine tablets versus alternative disease modifying treatments in active relapsing-remitting multiple sclerosis: adjusting for patient characteristics using meta-regression and matching-adjusted indirect treatment comparison approaches.
    Berardi A; Siddiqui MK; Treharne C; Harty G; Wong SL
    Curr Med Res Opin; 2019 Aug; 35(8):1371-1378. PubMed ID: 30786783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.